Among active 13F managers last quarter, 5 opened and 26 added, while 20 reduced; the largest holder to move was D. E. Shaw & Co., Inc. (−2.8%). Over the last 180 days, 4 insiders sold and none bought, a net -$1.1M in open-market trades.
The legs disagree, or only one of them leans.
214 tracked 13F filers disclose a position in PCRX as of the latest SEC 13F filings, a combined $991.6M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.7M | $170.1M | ▼−0.4% Reduced · −30K sh | Q2 2026 | |
| 2 | Doma Perpetual Capital Management LLC | 2.8M | $70.5M | —Held | Q2 2026 | |
| 3 | Vanguard Portfolio Management LLC | 2.4M | $61.0M | ▼−3.8% Reduced · −95K sh | Q2 2026 | |
| 4 | Dimensional Fund Advisors LP | 2.1M | $46.6M | ▲+5.7% Added · +111K sh | Q1 2026 | |
| 5 | State Street Corp | 2.1M | $52.3M | ▲+7.3% Added · +140K sh | Q2 2026 | |
| 6 | D. E. Shaw & Co., Inc. | 2.0M | $44.8M | ▼−2.8% Reduced · −57K sh | Q1 2026 | |
| 7 | Renaissance Technologies LLC | 1.8M | $41.3M | ▼−3.1% Reduced · −59K sh | Q1 2026 | |
| 8 | Vanguard Capital Management LLC | 1.7M | $42.9M | ▼−5.2% Reduced · −92K sh | Q2 2026 | |
| 9 | Goldman Sachs Group Inc | 1.6M | $35.5M | ▲+21% Added · +270K sh | Q1 2026 | |
| 10 | Morgan Stanley | 1.4M | $31.5M | ▲+17% Added · +200K sh | Q1 2026 | |
| 11 | Geode Capital Management, LLC | 1.2M | $29.4M | ▲+1.3% Added · +15K sh | Q2 2026 | |
| 12 | American Century Companies Inc | 838K | $18.9M | ▼−37% Reduced · −498K sh | Q1 2026 | |
| 13 | Impax Asset Management Group plc | 750K | $19.0M | —Held | Q2 2026 | |
| 14 | Charles Schwab Investment Management Inc | 732K | $16.5M | ▲+8.2% Added · +56K sh | Q1 2026 | |
| 15 | Gagnon Securities LLC | 609K | $15.4M | ▼−1.4% Reduced · −9K sh | Q2 2026 | |
| 16 | UBS Group AG | 562K | $12.7M | ▲+0.6% Added · +3K sh | Q1 2026 | |
| 17 | Two Sigma Investments, LP | 527K | $11.9M | ▲+17% Added · +75K sh | Q1 2026 | |
| 18 | Northern Trust Corp | 519K | $11.7M | ▼−1.7% Reduced · −9K sh | Q1 2026 | |
| 19 | Bridgeway Capital Management, LLC | 411K | $10.4M | —Held | Q2 2026 | |
| 20 | Deutsche Bank AG | 392K | $8.9M | ▲+1.1% Added · +4K sh | Q1 2026 | |
| 21 | Jefferies Financial Group Inc. | 370K | $9.4M | ▲+89% Added · +174K sh | Q2 2026 | |
| 22 | Gagnon Advisors, LLC | 353K | $8.9M | —Held | Q2 2026 | |
| 23 | Easterly Investment Partners LLC | 337K | $8.6M | ▲+0.6% Added · +2K sh | Q2 2026 | |
| 24 | Hillsdale Investment Management Inc. | 331K | $7.5M | ▲+7.5% Added · +23K sh | Q1 2026 | |
| 25 | Bridge City Capital, LLC | 312K | $7.9M | ▼−22% Reduced · −90K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 5 funds opened a new position in PCRX and 26 added to an existing one, while 20 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 119 funds | $328.1B |
| Microsoft CorpMSFT | 119 funds | $207.6B |
| Apple IncAAPL | 116 funds | $238.9B |
| Amazon.com IncAMZN | 116 funds | $160.8B |
| Meta Platforms Inc-Class AMETA | 114 funds | $87.1B |
| Alphabet Inc-CL AGOOGL | 113 funds | $139.7B |
| Broadcom IncAVGO | 113 funds | $133.2B |
| Eli Lilly & CoLLY | 113 funds | $67.2B |
| Advanced Micro DevicesAMD | 112 funds | $45.2B |
| Tesla IncTSLA | 111 funds | $59.9B |
| JPMorgan Chase & CoJPM | 111 funds | $46.7B |
| Visa Inc-Class A SharesV | 111 funds | $46.3B |
Ranked by how many of PCRX's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in PCRX.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 17, 2026 | Slonin Jonathan | Chief Medical Officer | Sell (S) | 3K | $71K |
| Jun 11, 2026 | Riker Lauren | Senior Vice President, Finance | Sell (S) | 6K | $144K |
| Jun 4, 2026 | Williams Kristen | Chief Administrative Officer | Sell (S) | 10K | $228K |
| Apr 23, 2026 | Cross Shawn | Chief Financial Officer | Sell (S) | 13K | $326K |
| Apr 22, 2026 | Cross Shawn | Chief Financial Officer | Sell (S) | 2K | $38K |
| Apr 21, 2026 | Cross Shawn | Chief Financial Officer | Sell (S) | 3K | $71K |
| Apr 20, 2026 | Cross Shawn | Chief Financial Officer | Sell (S) | 8K | $194K |
| Mar 17, 2026 | Froimson Mark | Director | Sell (S) | 500 | $11K |
| Mar 17, 2026 | Slonin Jonathan | Chief Medical Officer | Sell (S) | 3K | $74K |
| Feb 2, 2026 | Williams Kristen | Chief Administrative Officer | Sell (S) | 13K | $270K |
| Feb 2, 2026 | Riker Lauren | Senior Vice President, Finance | Sell (S) | 4K | $83K |
| Jan 5, 2026 | Riker Lauren | Senior Vice President, Finance | Sell (S) | 1K | $34K |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 48 | 39 | – |
Insiders Form 4 open-market | 0 | 4 | -$1.1M |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
No filings captured for this ticker in the live stream yet.
Connected entities for PCRX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/PCRX/capital-change-brief"
Use Arkolith's capital_change_brief for PCRX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for PCRX. Filings are public domain, sourced to SEC EDGAR.